Search Results - "Morris, Earl J."

Evaluating the use of prescription sequence symmetry analysis as a pharmacovigilance tool: A scoping review by Morris, Earl J., Hollmann, Josef, Hofer, Ann-Kathrin, Bhagwandass, Hemita, Oueini, Razanne, Adkins, Lauren E., Hallas, Jesper, Vouri, Scott M.

“…The (prescription) sequence symmetry analysis (PSSA) design has been used to identify potential prescribing cascade signals by assessing the prescribing…”
Get full text

Much Ado about Dosing: The Needs and Challenges of Defining a Standardized Cannabis Unit by Jugl, Sebastian, Sajdeya, Ruba, Morris, Earl J., Goodin, Amie J., Brown, Joshua D.

Get full text

A Mapping Literature Review of Medical Cannabis Clinical Outcomes and Quality of Evidence in Approved Conditions in the USA from 2016 to 2019 by Jugl, Sebastian, Okpeku, Aimalohi, Costales, Brianna, Morris, Earl J., Alipour-Haris, Golnoosh, Hincapie-Castillo, Juan M., Stetten, Nichole E., Sajdeya, Ruba, Keshwani, Shailina, Joseph, Verlin, Zhang, Yahan, Shen, Yun, Adkins, Lauren, Winterstein, Almut G., Goodin, Amie

“…In 2017, a National Academies of Sciences, Engineering, and Medicine (NASEM) report comprehensively evaluated the body of evidence regarding cannabis health…”
Get full text

Trends and Components of Thyroid Status Evaluation in Commercially Insured Adults in the United States, 2006-2020 by Morris, Earl J, Vouri, Scott M, Maraka, Spyridoula, Singh Ospina, Naykky

“…Abstract Context Thyroid-stimulating hormone (TSH) is one of the most ordered laboratory tests. Objective Determine trends of TSH testing rates and components…”
Get full text

Evaluating Provider and Pharmacy Discordance in Potential Calcium Channel Blocker–Loop Diuretic Prescribing Cascade by Ndai, Asinamai M., Morris, Earl J., Winterstein, Almut G., Vouri, Scott M.

“…Background Prescribing cascades occur when a drug-induced adverse event is treated with a new medication. Identifying clinical scenarios in which prescribing…”
Get full text

Continued potassium supplementation use following loop diuretic discontinuation in older adults: An evaluation of a prescribing cascade relic by Wang, Grace Hsin-Min, Morris, Earl J, Smith, Steven M, Hallas, Jesper, Vouri, Scott M

“…The use of a new medication (e.g., potassium supplementation) for managing a drug-induced adverse event (e.g., loop diuretic-induced hypokalemia) constitutes a…”
Get full text

Differences in Health-Related Quality of Life Among Adults with a Potential Dihydropyridine Calcium Channel Blocker–Loop Diuretic Prescribing Cascade by Morris, Earl J., Brown, Joshua D., Manini, Todd M., Vouri, Scott M.

“…Background Dihydropyridine calcium channel blockers (DH CCBs) are commonly used for hypertension in older adults. However, loop diuretics can be…”
Get full text

Use of negative controls in a prescription sequence symmetry analysis to reduce time‐varying bias by Vouri, Scott Martin, Jiang, Xinyi, Morris, Earl J., Brumback, Babette A., Winterstein, Almut G.

“…Purpose There is an increased use in the (prescription) sequence symmetry analysis (PSSA); however, limited studies have incorporated a negative control, and…”
Get full text

Association between gabapentinoids and oedema treated with loop diuretics: A pooled sequence symmetry analysis from the USA and Denmark by Vouri, Scott Martin, Morris, Earl J., Wang, Grace Hsin‐Min, Hashim Jaber Bilal, Alyaa, Hallas, Jesper, Henriksen, Daniel Pilsgaard

“…Aims To assess the gabapentinoid–oedema–loop diuretic prescribing cascade in adults using large administrative health care databases from the USA and Denmark…”
Get full text

Evaluation of a Beta-Blocker-Edema-Loop Diuretic Prescribing Cascade: A Prescription Sequence Symmetry Analysis by Vouri, Scott Martin, Morris, Earl J, Jiang, Xinyi, Hofer, Ann-Kathrin, Schmidt, Stephan, Pepine, Carl, Winterstein, Almut G, Smith, Steven M

“…Drug-related adverse events associated with antihypertensive therapy may result in subsequent prescribing of other potentially harmful medications, known as…”
Get full text

Which older adults are at highest risk of prescribing cascades? A national study of the gabapentinoid-loop diuretic cascade by Growdon, Matthew E, Jing, Bocheng, Morris, Earl J, Deardorff, W James, Boscardin, W John, Byers, Amy L, Boockvar, Kenneth S, Steinman, Michael A

“…Prescribing cascades are important contributors to polypharmacy. Little is known about which older adults are at highest risk of experiencing prescribing…”
Get full text

Antitumor properties of novel sesquiterpene lactone analogs as NFκB inhibitors that bind to the IKKβ ubiquitin-like domain (ULD) by Penthala, Narsimha R., Balasubramaniam, Meenakshisundaram, Dachavaram, Soma Shekar, Morris, Earl J., Bhat-Nakshatri, Poornima, Ponder, Jessica, Jordan, Craig T., Nakshatri, Harikrishna, Crooks, Peter A.

“…Melampomagnolide B (MMB, 3) is a parthenolide (PTL, 1) based sesquiterpene lactone that has been used as a template for the synthesis of a plethora of lead…”
Get full text

High‐throughput screening for prescribing cascades among real world statin initiators by Vouri, Scott M., Morris, Earl J., Walsh, Marta, Agalliu, Jessica, Dempsey, Alyssa, Hochleitner, Leonie, Muschett, Matthew R., Schmidt, Stephan, Pepine, Carl J., Smith, Steven M.

“…Purpose Statins are among the most prevalent medications prescribed and associated with adverse events that may prompt additional treatment (i.e., a…”
Get full text

Analysis of Prescriptions Dispensed After Death and Associated Medicare Spending Following Reimbursement Policy Changes in Medicare by Vouri, Scott M, Morris, Earl J, Zhang, Yongkang

“…This cohort study examined the association of a prescription drug event edit policy change with prescriptions dispensed after the deaths of beneficiaries and…”
Get full text

Evaluation of the key prescription sequence symmetry analysis assumption using the calcium channel blocker: Loop diuretic prescribing cascade by Vouri, Scott M., Morris, Earl J., Usmani, Silken A., Reise, Rachel, Jiang, Xinyi, Pepine, Carl J., Manini, Todd M., Malone, Daniel C., Winterstein, Almut G.

“…Objectives To evaluate the prescription sequence symmetry analysis assumption regarding balance between marker drug (i.e., medication used to treat a…”
Get full text

Trajectories of Sacubitril/Valsartan Adherence Among Medicare Beneficiaries With Heart Failure by Huang, Wenxi, Ahmed, Mustafa M., Morris, Earl J., Yang, Lanting, O'Neal, Latoya, Hernandez, Inmaculada, Bian, Jiang, Kimmel, Stephen E., Smith, Steven, Guo, Jingchuan

“…Sacubitril/valsartan, an angiotensin receptor/neprilysin inhibitor (ARNi), improves heart failure (HF) outcomes, yet real-world adherence patterns are not well…”
Get full text

Skills laboratory faculty job satisfaction: Effects of high-contact teaching and the COVID-19 pandemic by Anksorus, Heidi N., Bradley, Courtney L., Morris, Earl J., Sourial, Mariette, Donohoe, Krista L., Curtis, Stacey D.

“…The objective of this study is to describe the workload responsibilities and job satisfaction of skills laboratory faculty, both before and during the COVID-19…”
Get full text

A lot in a little: Assessment of skills laboratory course structures and faculty workloads by Bradley, Courtney L, Curtis, Stacey D, Morris, Earl J, Anksorus, Heidi N, Sourial, Mariette, Donohoe, Krista L

“…Pharmacy skills development is essential to pharmacy programs to ensure "practice-ready" graduates. The objective was to describe the landscape of skills…”
Get full text

Pharmacy Students’ Lived Experiences of Academic Difficulty and Tinto’s Theory of Student Departure by Choi, Angie N., Curran, Geoffrey M., Morris, Earl J., Salem, Ahmed M., Curry, Brent D., Flowers, Schwanda K.

“…Objective. To understand students’ lived experiences of academic difficulty in pharmacy school in relation to Tinto’s conceptual schema of student departure…”
Get full text

FRI528 Trends And Components Of Thyroid Status Evaluation In Commercially Insured Adults In The US, 2006-2020 by Morris, Earl J, Singh Ospina, Naykky Maruquel, Maraka, Spyridoula, Vouri, Scott M

“…Abstract Disclosure: E.J. Morris: None. N.M. Singh Ospina: None. S. Maraka: None. S.M. Vouri: Employee; Self; Pfizer, Inc. Background. In clinical practice,…”
Get full text